• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease.晚期慢性肾脏病老年患者中完整型和C末端成纤维细胞生长因子23与炎症标志物的关联
J Clin Med. 2024 Jul 6;13(13):3967. doi: 10.3390/jcm13133967.
2
Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients.成纤维细胞生长因子 23 评估老年慢性肾脏病患者椎体骨折和慢性肾脏病-矿物质和骨异常风险的适用性。
BMC Nephrol. 2012 Sep 26;13:122. doi: 10.1186/1471-2369-13-122.
3
Associations of Fibroblast Growth Factor 23 with Markers of Inflammation and Leukocyte Transmigration in Chronic Kidney Disease.成纤维细胞生长因子23与慢性肾脏病炎症标志物及白细胞迁移的相关性
Nephron. 2018;138(4):287-295. doi: 10.1159/000485472. Epub 2018 Jan 4.
4
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.炎症和功能性铁缺乏调节成纤维细胞生长因子23的产生。
Kidney Int. 2016 Jan;89(1):135-46. doi: 10.1038/ki.2015.290. Epub 2016 Jan 4.
5
Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease.与慢性肾脏病患儿血清成纤维细胞生长因子 23 水平 1 年变化相关的因素。
Clin Exp Nephrol. 2022 Oct;26(10):1014-1021. doi: 10.1007/s10157-022-02238-5. Epub 2022 May 25.
6
Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.慢性肾脏病患者急性炎症/脓毒症期间完整的成纤维细胞生长因子23(FGF23)和α-klotho
Eur J Clin Invest. 2016 Mar;46(3):234-41. doi: 10.1111/eci.12588. Epub 2016 Jan 21.
7
Associations between anemia and FGF23 in the CKiD study.慢性肾脏病队列研究中贫血与成纤维细胞生长因子23之间的关联。
Pediatr Nephrol. 2024 Mar;39(3):837-847. doi: 10.1007/s00467-023-06160-0. Epub 2023 Sep 26.
8
Spleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation.脾脏在对脂多糖诱导的炎症反应中,对成纤维细胞生长因子23循环水平的升高有显著作用。
Nephrol Dial Transplant. 2017 Jun 1;32(6):960-968. doi: 10.1093/ndt/gfw376.
9
FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease.成纤维细胞生长因子 23 作为慢性肾脏病相关外周动脉疾病的潜在病理生理因素。
Int J Mol Sci. 2024 May 17;25(10):5457. doi: 10.3390/ijms25105457.
10
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.成纤维细胞生长因子23(FGF23)可预测慢性肾脏病的进展:轻至中度肾脏病(MMKD)研究
J Am Soc Nephrol. 2007 Sep;18(9):2600-8. doi: 10.1681/ASN.2006080936. Epub 2007 Jul 26.

引用本文的文献

1
Association between complete blood count-derived inflammatory biomarkers and renal failure: a cross-sectional study from NHANES 2007-2020.全血细胞计数衍生的炎症生物标志物与肾衰竭之间的关联:一项来自2007 - 2020年美国国家健康与营养检查调查(NHANES)的横断面研究。
BMJ Open. 2025 Sep 1;15(9):e103381. doi: 10.1136/bmjopen-2025-103381.
2
Pathophysiology of chronic kidney disease-mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis.慢性肾脏病-矿物质与骨异常(CKD-MBD)的病理生理学:从适应性矿物质稳态到适应性不良的矿物质稳态。
Clin Kidney J. 2025 Mar 13;18(Suppl 1):i3-i14. doi: 10.1093/ckj/sfae431. eCollection 2025 Mar.
3
Uric Acid Correlates with Serum Levels of Mineral Bone Metabolism and Inflammation Biomarkers in Patients with Stage 3a-5 Chronic Kidney Disease.尿酸与3a - 5期慢性肾脏病患者的血清矿物质骨代谢及炎症生物标志物水平相关。
Medicina (Kaunas). 2024 Dec 19;60(12):2081. doi: 10.3390/medicina60122081.

本文引用的文献

1
Is there a role in acute kidney injury for FGF23 and Klotho?成纤维细胞生长因子23(FGF23)和klotho在急性肾损伤中起作用吗?
Clin Kidney J. 2023 Apr 25;16(10):1555-1562. doi: 10.1093/ckj/sfad093. eCollection 2023 Oct.
2
Inflammation and gut dysbiosis as drivers of CKD-MBD.炎症和肠道菌群失调作为 CKD-MBD 的驱动因素。
Nat Rev Nephrol. 2023 Oct;19(10):646-657. doi: 10.1038/s41581-023-00736-7. Epub 2023 Jul 24.
3
The Role of Inflammation in CKD.炎症在慢性肾脏病中的作用。
Cells. 2023 Jun 7;12(12):1581. doi: 10.3390/cells12121581.
4
Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation.骨源 C 端 FGF23 裂解肽增加急性炎症中铁的可用性。
Blood. 2023 Jul 6;142(1):106-118. doi: 10.1182/blood.2022018475.
5
FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia.成纤维细胞生长因子 23 在慢性肾脏病中的作用:连接心脏和贫血。
Cells. 2023 Feb 13;12(4):609. doi: 10.3390/cells12040609.
6
The cardiovascular-renal link and the health burden of kidney failure.心血管-肾脏关联与肾衰竭的健康负担。
Eur Heart J. 2023 Apr 1;44(13):1167-1169. doi: 10.1093/eurheartj/ehad039.
7
MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD.单核细胞趋化蛋白1可能介导慢性肾脏病中FGF23与ω-6/ω-3相关性的反转。
J Clin Med. 2022 Nov 30;11(23):7099. doi: 10.3390/jcm11237099.
8
Evolving Concepts on Inflammatory Biomarkers and Malnutrition in Chronic Kidney Disease.慢性肾脏病中炎症生物标志物和营养不良相关概念的演变。
Nutrients. 2022 Oct 14;14(20):4297. doi: 10.3390/nu14204297.
9
Epidemiology of chronic kidney disease: an update 2022.慢性肾脏病流行病学:2022年最新情况
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.
10
Pro-Inflammatory Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and Cardiovascular Risk in Chronic Kidney Disease.肥胖症中脂肪细胞因子的促炎特征导致慢性肾脏病的发病机制、营养障碍和心血管风险。
Nutrients. 2022 Mar 31;14(7):1457. doi: 10.3390/nu14071457.

晚期慢性肾脏病老年患者中完整型和C末端成纤维细胞生长因子23与炎症标志物的关联

Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease.

作者信息

Abinti Matteo, Vettoretti Simone, Caldiroli Lara, Mattinzoli Deborah, Ikehata Masami, Armelloni Silvia, Molinari Paolo, Alfieri Carlo Maria, Castellano Giuseppe, Messa Piergiorgio

机构信息

Department of Nephrology, Dialysis and Renal Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.

出版信息

J Clin Med. 2024 Jul 6;13(13):3967. doi: 10.3390/jcm13133967.

DOI:10.3390/jcm13133967
PMID:38999530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11242756/
Abstract

: In patients with chronic kidney disease (CKD), Fibroblast Growth Factor 23 (FGF23) is markedly increased and has been proposed to interact with systemic inflammation. : In this cross-sectional study, we evaluated the correlations of intact FGF23, c-terminal FGF23, and the FGF23 ratio (c-terminal to intact) with some inflammatory cytokines in 111 elderly patients with advanced CKD not yet in dialysis. : Estimated glomerular filtration rate (eGFR) was inversely correlated with intact FGF23 and c-terminal FGF23, as well as with interleukin 6 (IL-6), tumor necrosis factor alpha (TNFα), and monocyte chemoattractant protein-1 (MCP-1). Intact FGF23 levels were directly correlated with IL-6 (r = 0.403; < 0.001) and TNFα (r = 0.401; < 0.001) while c-terminal FGF23 was directly correlated with MCP-1 (r = 0.264; = 0.005). The FGF23 ratio was, instead, inversely correlated with IL-6 (r = -0.326; < 0.001). Multivariate analysis revealed that intact FGF23 was directly associated with TNFα [B = 0.012 (95% CI 0.006, 0.019); = 0.003] and c-terminal FGF23 was directly associated with MCP-1 [B = 0.001 (95% CI 0.000, 0.002); = 0.038], while the FGF23 ratio was inversely correlated with IL-6 [B = -0.028 (95% CI -0.047, -0.010); = 0.002]. : Our data demonstrate that, in CKD patients, intact FGF23 and the metabolites deriving from its proteolytic cleavage are differently associated with some inflammatory pathways. In particular, intact FGF23 is mainly associated with IL-6 and TNFα, c-terminal FGF23 with MCP-1, and the FGF23 ratio with IL6.

摘要

在慢性肾脏病(CKD)患者中,成纤维细胞生长因子23(FGF23)显著升高,并且有人提出它与全身炎症相互作用。在这项横断面研究中,我们评估了111例尚未进行透析的晚期CKD老年患者中完整FGF23、C末端FGF23以及FGF23比值(C末端与完整的比值)与一些炎性细胞因子之间的相关性。估计肾小球滤过率(eGFR)与完整FGF23、C末端FGF23以及白细胞介素6(IL-6)、肿瘤坏死因子α(TNFα)和单核细胞趋化蛋白-1(MCP-1)呈负相关。完整FGF23水平与IL-6(r = 0.403;P < 0.001)和TNFα(r = 0.401;P < 0.001)直接相关,而C末端FGF23与MCP-1直接相关(r = 0.264;P = 0.005)。相反,FGF23比值与IL-6呈负相关(r = -0.326;P < 0.001)。多变量分析显示,完整FGF23与TNFα直接相关[B = 0.012(95%CI 0.006,0.019);P = 0.003],C末端FGF23与MCP-1直接相关[B = 0.001(95%CI 0.000,0.002);P = 0.038],而FGF23比值与IL-6呈负相关[B = -0.028(95%CI -0.047,-0.010);P = 0.002]。我们的数据表明,在CKD患者中,完整FGF23及其蛋白水解裂解产生的代谢产物与一些炎症途径的关联不同。特别是,完整FGF23主要与IL-6和TNFα相关,C末端FGF23与MCP-1相关,FGF23比值与IL-6相关。